These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16495267)

  • 1. Mefloquine induces dose-related neurological effects in a rat model.
    Dow G; Bauman R; Caridha D; Cabezas M; Du F; Gomez-Lobo R; Park M; Smith K; Cannard K
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1045-53. PubMed ID: 16495267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons.
    Hood JE; Jenkins JW; Milatovic D; Rongzhu L; Aschner M
    Neurotoxicology; 2010 Sep; 31(5):518-23. PubMed ID: 20562019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children.
    Guidi M; Mercier T; Aouri M; Decosterd LA; Csajka C; Ogutu B; Carn G; Kiechel JR
    Malar J; 2019 Apr; 18(1):139. PubMed ID: 30999915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Lipid Levels with Mefloquine and Carboxy-Mefloquine Concentrations in Patients with Uncomplicated Falciparum Malaria.
    Vieira JLF; Rivera JGB; de Sena LWP; Ferreira MVD
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety.
    Frey SG; Chelo D; Kinkela MN; Djoukoue F; Tietche F; Hatz C; Weber P
    Malar J; 2010 Oct; 9():291. PubMed ID: 20964849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria.
    Sirivichayakul C; Sabchareon A; Pengsaa K; Thaiarporn I; Chaivisuth A; Na-Bangchang K; Wisetsing P; Chanthavanich P; Pojjaroen-Anant C
    Ann Trop Paediatr; 2007 Mar; 27(1):17-24. PubMed ID: 17469728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
    Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
    Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic interactions of mefloquine and dihydroartemisinin.
    Na-Bangchang K; Tippawangkosol P; Thanavibul A; Ubalee R; Karbwang J
    Int J Clin Pharmacol Res; 1999; 19(1):9-17. PubMed ID: 10450538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mefloquine effect on disposition of halofantrine in the isolated perfused rat liver.
    Leo KU; Wesche DL; Marino MT; Brewer TG
    J Pharm Pharmacol; 1996 Jul; 48(7):723-8. PubMed ID: 8866337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with a 2 day course of artemether-mefloquine in an area of highly multi-drug resistant Plasmodium falciparum malaria.
    Na-Bangchang K; Congpuong K; Sirichaisinthop J; Suprakorb K; Karbwang J
    Br J Clin Pharmacol; 1997 Jun; 43(6):639-42. PubMed ID: 9205825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
    Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J
    Malar J; 2013 Jul; 12():263. PubMed ID: 23898808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
    Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria.
    Supanaranond W; Suputtamongkol Y; Davis TM; Pukrittayakamee S; Teja-Isavadharm P; Webster HK; White NJ
    Trans R Soc Trop Med Hyg; 1997; 91(6):694-6. PubMed ID: 9509182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mefloquine concentration profiles during prophylactic dose regimens.
    Kollaritsch H; Karbwang J; Wiedermann G; Mikolasek A; Na-Bangchang K; Wernsdorfer WH
    Wien Klin Wochenschr; 2000 May; 112(10):441-7. PubMed ID: 10890135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological assessments after treatment with the antimalarial β-arteether in neonatal and adult rats.
    Erickson RI; Defensor EB; Fairchild DG; Mirsalis JC; Steinmetz KL
    Neurotoxicology; 2011 Aug; 32(4):432-40. PubMed ID: 21477617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
    Svensson US; Alin H; Karlsson MO; Bergqvist Y; Ashton M
    Eur J Clin Pharmacol; 2002 Aug; 58(5):339-51. PubMed ID: 12185558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high performance liquid chromatographic assay of mefloquine in saliva after a single oral dose in healthy adult Africans.
    Gbotosho GO; Happi CT; Lawal O; Sijuade A; Sowunmi A; Oduola A
    Malar J; 2012 Feb; 11():59. PubMed ID: 22369125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers.
    Bindschedler M; Lefèvre G; Ezzet F; Schaeffer N; Meyer I; Thomsen MS
    Eur J Clin Pharmacol; 2000 Aug; 56(5):375-81. PubMed ID: 11009045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
    Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
    Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.